Top

Published in:

Open Access 01-08-2014 | Bone and Soft Tissue Sarcomas

Incidence Patterns of Primary Bone Cancer in Taiwan (2003–2010): A Population-Based Study

Authors: Giun-Yi Hung, MD, Jiun-Lin Horng, PhD, Hsiu-Ju Yen, MD, Chueh-Chuan Yen, MD, PhD, Wei-Ming Chen, MD, Paul Chih-Hsueh Chen, MD, Hung-Ta Hondar Wu, MD, Hong-Jen Chiou, MD

Published in: Annals of Surgical Oncology | Issue 8/2014

Abstract

Background

Primary bone cancer (BC) incidence by age has not been surveyed in Asia.

Methods

The incidence patterns of nine subtypes of primary BCs registered between 2003 and 2010 were analyzed from Taiwan cancer registry data. More specific analyses were conducted within age groups (Group I: 0–24 years; Group II: 25–59 years; and Group III: 60–85+ years).

Results

A total of 1,238 newly diagnosed subjects were registered with an age-standardized incidence rate (ASR) of 6.70 per million person-years. Overall, osteosarcoma (OS: 45 %) was the most common, followed by chondrosarcoma (CS: 18 %), and Ewing sarcoma (ES: 8 %). The percentages of cases and ASRs for age groups I, II, and III were 36.3, 43.0, and 20.7 %, and 7.00, 5.48, and 10.28 per million, respectively. Significant male predilections were observed for all BCs combined, and the CS, chordoma, and malignant ameloblastoma subtypes. Our findings demonstrated an upward trend of 4.8 % per year over the study period, and was more significant for females (6.7 %). A significant increase in trend existed in the incidence of BC among females in Group II, and the incidence of OS and ES among females in Group I.

Conclusions

This population-based study has allowed us to confidently define the incidence rates among three age groups of Taiwanese. Despite overall low rates, the upward trend in BC incidence among females may invoke a concern. The results suggest areas for further study into the underlying causes for these cancer trends.

Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL. Cancer incidence among children and adolescents in the United States, 2001–2003. Pediatrics. 2008;121:e1470–77.PubMedCrossRef

Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115:1531–43.PubMedCentralPubMedCrossRef

Anfinsen KP, Devesa SS, Bray F, Troisi R, Jonasdottir TJ, Bruland OS, et al. Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976–2005). Cancer Epidemiol Biomarkers Prev. 2011;20:1770–77.PubMedCrossRef

Guo W, Xu W, Huvos AG, Healey JH, Feng C. Comparative frequency of bone sarcomas among different racial groups. Chin Med J (Engl). 1999;112:1101–4.PubMed

Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125:229–34.PubMedCentralPubMedCrossRef

Chiang CJ, Chen YC, Chen CJ, You SL, Lai MS. Taiwan cancer registry task force. Cancer trends in Taiwan. Jpn J Clin Oncol. 2010;40:897–904.PubMedCrossRef

Monthly bulletin of interior statistics [e-book]. 1.1 Number of villages, neighborhoods, households and resident population; 1.4 indigenous people. Available from http://sowf.moi.gov.tw/stat/month/elist.htm. Accessed 5 Apr 2013.

Taiwan Cancer Registry annual report. Taiwan: health promotion administration, ministry of health and welfare. Available from http://www.hpa.gov.tw/Bhpnet/Web/Stat/StatisticsShow.aspx?No=200911300001. Accessed 5 Apr 2013.

Percy C, Fritz A, Ries L. Conversion of neoplasms by topography and morphology, from the international classification of diseases for oncology, second edition to international classification of diseases for oncology, third edition. Cancer statistics branch, DCCPS, SEER program: National Cancer Institute, 2001. Available from http://seer.cancer.gov/tools/conversion/ICDO2-3manual.pdf. Accessed 18 Sep 2013.

10.

Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. Cancer registration: principles and methods. Lyon: IARC Scientific Publications; 1991:126–58. Available from http://www.iarc.fr/en/publications/pdfs-online/epi/sp95/sp95-chap11.pdf. Accessed 2 Apr 2013.

11.

Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.PubMedCrossRef

12.

Whelan J, McTiernan A, Cooper N, Wong YK, Francis M, Vernon S, et al. Incidence and survival of malignant bone sarcomas in England 1979–2007. Int J Cancer. 2012;131:E508–17.PubMedCrossRef

13.

Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, et al; RARECARE working group. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer. 2013;49:684–95.PubMedCrossRef

14.

Curado MP, Edwards B, Shin HR, Storm H, Feraly J, Heanue M, et al. Cancer incidence in five continents. Vol. IX. Lyon: IARC Scientific Publications; 2007:712–7. Available from http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/. Accessed 6 Oct 2013.

15.

Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973–2005. Cancer. 2009;115:3526–36.PubMedCrossRef

16.

Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am. 2006;37:35–51.PubMedCrossRef

17.

Beebe-Dimmer JL, Cetin K, Fryzek JP, Schuetze SM, Schwartz K. The epidemiology of malignant giant cell tumors of bone: an analysis of data from the surveillance, epidemiology and end results program (1975–2004). Rare Tumors. 2009;1:e52.PubMedCentralPubMed

18.

Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, et al. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am. 2012;94:461–7.PubMedCrossRef

19.

McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control. 2001;12:1–11.PubMedCrossRef

20.

Smoll NR, Gautschi OP, Radovanovic I, Schaller K, Weber DC. Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population. Cancer. 2013;119:2029–37.PubMedCrossRef

21.

Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006;96:252–61.PubMedCentralPubMedCrossRef

22.

Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality: a review of recent evidence. Autoimmun Rev. 2013;12:976–89.PubMedCrossRef

23.

Lee MS, Li HL, Hung TH, Chang HY, Yang FL, Wahlqvist ML. Vitamin D intake and its food sources in Taiwanese. Asia Pac J Clin Nutr. 2008;7:397–407.

24.

Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15:36–47.PubMed

25.

Schüler S, Ponnath M, Engel J, Ortmann O. Ovarian epithelial tumors and reproductive factors: a systematic review. Arch Gynecol Obstet. 2013;287:1187–204.PubMedCrossRef

26.

Statistical yearbook of interior. 02–04 Fertility rates of childbearing age women. Available from http://sowf.moi.gov.tw/stat/year/list.htm. Accessed 5 Apr 2013.

27.

2010 National Report of the Assisted Reproductive Technology Summary in Taiwan. Available from http://www.bhp.doh.gov.tw/BHPNet/English/file/ContentFile/201210020413361250/2010%20ART%20Report.pdf. Accessed 5 Apr 2013.

28.

Chen HY, Lin YH, Wu JC, et al. Characteristics of pediatric traditional Chinese medicine users in Taiwan: a nationwide cohort study. Pediatrics. 2012;129:e1485–92.PubMedCrossRef

29.

Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004;7:187–200.PubMedCrossRef

30.

Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66:1191–308.PubMed

Title: Incidence Patterns of Primary Bone Cancer in Taiwan (2003–2010): A Population-Based Study
Authors: Giun-Yi Hung, MD
Jiun-Lin Horng, PhD
Hsiu-Ju Yen, MD
Chueh-Chuan Yen, MD, PhD
Wei-Ming Chen, MD
Paul Chih-Hsueh Chen, MD
Hung-Ta Hondar Wu, MD
Hong-Jen Chiou, MD
Publication date: 01-08-2014
Publisher: Springer US
Published in: Annals of Surgical Oncology / Issue 8/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-014-3697-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Incidence Patterns of Primary Bone Cancer in Taiwan (2003–2010): A Population-Based Study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2014

The Clinical Behavior of Transplantable Recurrent Hepatocellular Carcinoma After Curative Resection: Implications for Salvage Liver Transplantation

The Frequencies and Clinical Implications of Mutations in 33 Kinase-Related Genes in Locally Advanced Rectal Cancer: A Pilot Study

The Impact of Surgical Volume on Racial Disparity in Thyroid and Parathyroid Surgery

Implementation of the American College of Surgeons Oncology Group Z1071 Trial Data in Clinical Practice: Is There a Way Forward for Sentinel Lymph Node Dissection in Clinically Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

Technique Selection of Bricker or Wallace Ureteroileal Anastomosis in Ileal Conduit Urinary Diversion: A Strategy Based on Patient Characteristics

Hospital and Geographic Variability in Two Colorectal Cancer Surgery Outcomes: Complications and Mortality After Complications